- Home
- BRKL vs ABCL Comparison
BRKL vs ABCL Comparison
Compare BRKL & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKL
- ABCL
- Stock Information
- Founded
- BRKL 1871
- ABCL 2012
- Country
- BRKL United States
- ABCL Canada
- Employees
- BRKL N/A
- ABCL N/A
- Industry
- BRKL Savings Institutions
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- BRKL Finance
- ABCL Health Care
- Exchange
- BRKL Nasdaq
- ABCL Nasdaq
- Market Cap
- BRKL 948.1M
- ABCL 1.1B
- IPO Year
- BRKL 1998
- ABCL 2020
- Fundamental
- Price
- BRKL $10.19
- ABCL $4.24
- Analyst Decision
- BRKL Buy
- ABCL Strong Buy
- Analyst Count
- BRKL 2
- ABCL 5
- Target Price
- BRKL $15.25
- ABCL $8.75
- AVG Volume (30 Days)
- BRKL 556.2K
- ABCL 6.7M
- Earning Date
- BRKL 07-23-2025
- ABCL 08-07-2025
- Dividend Yield
- BRKL 5.23%
- ABCL N/A
- EPS Growth
- BRKL 2.47
- ABCL N/A
- EPS
- BRKL 0.88
- ABCL N/A
- Revenue
- BRKL $345,393,000.00
- ABCL $23,114,000.00
- Revenue This Year
- BRKL $53.95
- ABCL N/A
- Revenue Next Year
- BRKL $68.33
- ABCL $71.11
- P/E Ratio
- BRKL $11.73
- ABCL N/A
- Revenue Growth
- BRKL 2.90
- ABCL N/A
- 52 Week Low
- BRKL $9.24
- ABCL $1.89
- 52 Week High
- BRKL $13.15
- ABCL $5.82
- Technical
- Relative Strength Index (RSI)
- BRKL 33.47
- ABCL 50.27
- Support Level
- BRKL $10.73
- ABCL $4.67
- Resistance Level
- BRKL $10.88
- ABCL $5.19
- Average True Range (ATR)
- BRKL 0.25
- ABCL 0.40
- MACD
- BRKL -0.11
- ABCL -0.09
- Stochastic Oscillator
- BRKL 13.33
- ABCL 18.97
About BRKL Brookline Bancorp Inc.
Brookline Bancorp Inc operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.